Phase 3 Motor Neurone Disease Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• You have been diagnosed with ALS (also called Lou Gehrig's disease), confirmed by recognized medical criteria.
• Your ALS may be inherited (runs in the family) or have appeared without a known family history.
• Your ALS was diagnosed no more than 24 months (2 years) before the screening visit for this trial.
• You have been taking a stable dose of riluzole (100 mg per day) for at least 12 weeks before the start of the trial.
• Your ALS symptoms have been getting worse at a certain minimum rate, based on a standard ALS function scoring tool, both before joining and during a 12-week observation period at the start of the trial (confirm with trial site for exact details).
• Your overall ability to function, as measured by a standard ALS scoring tool, meets certain minimum levels at both the screening and start-of-treatment visits (confirm with trial site for exact details).

Who may not be able to join:

• You have dementia or another significant brain, mental health, or serious physical condition that is not well controlled or could affect the trial results.
• Your lung function is below 60% of what would normally be expected for someone of your age, height, and sex.
• You are currently pregnant or breastfeeding.

Important: Always verify eligibility with the trial site directly before applying.